圣达生物
(603079)
| 流通市值：28.76亿 | | | 总市值：31.76亿 |
| 流通股本：1.71亿 | | | 总股本：1.89亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 621,284,743.25 | 400,730,585.4 | 203,225,651.02 | 827,401,959.68 |
| 营业收入 | 621,284,743.25 | 400,730,585.4 | 203,225,651.02 | 827,401,959.68 |
| 二、营业总成本 | 555,173,218.95 | 353,802,598.39 | 174,454,492.13 | 775,052,391.23 |
| 营业成本 | 459,539,665.95 | 289,224,241.02 | 144,500,426.11 | 651,452,036.05 |
| 税金及附加 | 8,054,006.37 | 5,098,878.78 | 2,634,795.27 | 11,105,308.87 |
| 销售费用 | 9,681,901.37 | 6,857,379.97 | 2,668,964.54 | 14,645,144.2 |
| 管理费用 | 47,344,909.47 | 31,410,388.53 | 14,864,798.75 | 63,843,516.05 |
| 研发费用 | 35,568,859.94 | 23,017,412.61 | 10,162,625.24 | 43,762,465.09 |
| 财务费用 | -5,016,124.15 | -1,805,702.52 | -377,117.78 | -9,756,079.03 |
| 其中:利息费用 | 863,818.11 | 429,308.17 | 250,833.34 | 2,076,164.12 |
| 其中:利息收入 | 6,395,360.85 | 1,578,311.31 | 644,875 | 7,951,083.85 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 302.64 | -958.36 | -756.6 | 1,210.56 |
| 加:投资收益 | 1,325,624.94 | 754,511.08 | 449,777.4 | 723,379.08 |
| 资产处置收益 | -125,651.57 | -86,177.7 | -86,177.7 | 145,968.82 |
| 资产减值损失(新) | -1,922,160.02 | -933,206.09 | -3,243,969.71 | -10,643,054.89 |
| 信用减值损失(新) | -556,275.8 | 163,447.07 | -627,119.21 | -5,462,103.38 |
| 其他收益 | 7,406,654.21 | 3,525,750.15 | 2,370,433.86 | 9,451,253.94 |
| 四、营业利润 | 72,240,018.7 | 50,351,353.16 | 27,633,346.93 | 46,566,222.58 |
| 加:营业外收入 | 467,218 | 155,885.39 | 104,456.49 | 11,171,213.82 |
| 减:营业外支出 | 607,716.71 | 241,710.8 | 1,420.42 | 8,652,161.83 |
| 五、利润总额 | 72,099,519.99 | 50,265,527.75 | 27,736,383 | 49,085,274.57 |
| 减:所得税费用 | 13,372,448.84 | 9,769,969.54 | 4,317,471.64 | 11,827,625.68 |
| 六、净利润 | 58,727,071.15 | 40,495,558.21 | 23,418,911.36 | 37,257,648.89 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 58,727,071.15 | 40,495,558.21 | 23,418,911.36 | 37,257,648.89 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 53,338,557.65 | 37,805,384.4 | 21,709,484.85 | 29,424,490.05 |
| 少数股东损益 | 5,388,513.5 | 2,690,173.81 | 1,709,426.51 | 7,833,158.84 |
| 扣除非经常损益后的净利润 | 47,487,685.97 | 35,058,781.8 | 19,717,813.27 | 22,464,100.77 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.3 | 0.22 | 0.13 | 0.17 |
| (二)稀释每股收益 | 0.3 | 0.22 | 0.13 | 0.17 |
| 九、综合收益总额 | 58,727,071.15 | 40,495,558.21 | 23,418,911.36 | 37,257,648.89 |
| 归属于母公司股东的综合收益总额 | 53,338,557.65 | 37,805,384.4 | 21,709,484.85 | 29,424,490.05 |
| 归属于少数股东的综合收益总额 | 5,388,513.5 | 2,690,173.81 | 1,709,426.51 | 7,833,158.84 |
| 公告日期 | 2025-10-30 | 2025-08-26 | 2025-04-28 | 2025-04-28 |
| 审计意见(境内) | | | | 标准无保留意见 |